Bevacizumab is a recombinant monoclonal antibody that blocks the growth of new blood vessels (angiogenesis). It is often used in the treatment of various advanced cancers. It is developed to prevent the growth of tumors. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. Bevacizumab Injection in Advanced Cancer Treatment